Trials / Withdrawn
WithdrawnNCT02624544
Proton Pump Inhibitors Use in Patients With Psoriasis
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Proton pump inhibitors act in blocking acid secretion and also have antioxidant and anti-inflammatory properties. For that mechanisms possibly PPIs may have an anti-inflammatory action with improvement in skin lesions in patients with psoriasis.
Detailed description
Proton pump inhibitors act in blocking acid secretion and also have antioxidant and anti-inflammatory properties. For that mechanisms possibly PPIs may have an anti-inflammatory action with improvement in skin lesions in patients with psoriasis. The study will assess the evolution of skin lesions in psoriasis patients using PPIs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | esomeprazole | esomex 40 mg twice daily |
| DRUG | desonide | topical corticosteroid desonid 0,1% b.i.d |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-01-01
- Completion
- 2016-12-01
- First posted
- 2015-12-08
- Last updated
- 2022-08-05
Source: ClinicalTrials.gov record NCT02624544. Inclusion in this directory is not an endorsement.